Ignite Creation Date:
2024-05-06 @ 7:42 PM
Last Modification Date:
2024-10-26 @ 3:12 PM
Study NCT ID:
NCT06102915
Status:
COMPLETED
Last Update Posted:
2023-11-28
First Post:
2023-10-22
Brief Title:
Rocuronium vs Cis-atracurium Do Rocuronium Still ROCKS In Coronary Artery Bypass Grafting
Sponsor:
Institut Jantung Negara
Organization:
Institut Jantung Negara
Study Overview
Official Title:
Rocuronium vs Cis-atracurium Do Rocuronium Still ROCKS In Coronary Artery Bypass Grafting
Status:
COMPLETED
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The current trend in most cardiac surgeries was to use rocuronium as it provides faster recovery in train-of-four ratio compared to other aminosteroid non-depolarising neuromuscular blocker However as most cardiac centres standard of care does not perform any neuromuscular monitoring nor antagonism of neuromuscular blockade effect residual neuromuscular blockade could potentially be the key to delayed extubation As such Cis-atracuriums organ-independent Hofmann elimination could be in favour
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None